Infinome Biosciences
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Infinome Biosciences - overview
Established
2021
Location
Boulder, CO, US
Primary Industry
Biotechnology
About
Based in Colorado, US, Infinome Biosciences operates as a biotechnological company that is engaged in biobased manufacturing processes that provides commercial enzyme engineering and manufacturing. The company creates the GenoScaler™ platform to enable rapid genome engineering for internal and external, partner-related opportunities. The platform integrates all components of genome engineering, such as genome-scale engineering, parallel CRISPR genome editing, rapid and low-cost strain library construction, machine learning, smart automation and analytics, predictive fermentation, and software and informatics to create microbial processes for flavors and fragrances, therapeutics, agriculture, food technology, bioremediation, and biomaterials.
Current Investors
Inscripta, Inc.
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Medical Devices & Equipment, Medical Software, Application Integration Software, Analytics & Performance Software
Verticals
Artificial Intelligence, HealthTech, Manufacturing
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.